2018
DOI: 10.1016/j.athoracsur.2018.03.014
|View full text |Cite
|
Sign up to set email alerts
|

Long-Term Outcome of Homograft Implants Related to Donor and Tissue Characteristics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5

Relationship

3
2

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 14 publications
0
6
0
Order By: Relevance
“…6 a). Studies comparing different ischemic times in relation to long-term performance of homografts have not been able to find any differences between homografts with ischemic times up to 24 h compared to a maximum of 48 h (Meyns et al 2005 ; Kalfa et al 2011 ; Axelsson and Malm 2018 ). Recent studies of decellularized homografts have shown promising results, indicating that cell viability in the homograft is not needed to ensure homograft quality at implantation.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…6 a). Studies comparing different ischemic times in relation to long-term performance of homografts have not been able to find any differences between homografts with ischemic times up to 24 h compared to a maximum of 48 h (Meyns et al 2005 ; Kalfa et al 2011 ; Axelsson and Malm 2018 ). Recent studies of decellularized homografts have shown promising results, indicating that cell viability in the homograft is not needed to ensure homograft quality at implantation.…”
Section: Discussionmentioning
confidence: 99%
“…In alliance with the EDQM guidelines, a blood sample is required from the donor for serological testing within 24 h of death to avoid hemolysis. After preparation, antibiotic decontamination is conducted for a minimum of 24 h and a maximum of 96 h. The allowed extended time spans lead to a larger pool of possible donors, and more time to retrieve and transport the hearts to the tissue bank (Axelsson and Malm 2018 ; Bester et al 2018 ).…”
Section: Introductionmentioning
confidence: 99%
“…The preparation, antibiotic decontamination and cryopreservation of the homograft have been described elsewhere (Axelsson and Malm 2018 ). During preparation, the cusps and vessels are closely reviewed for damage and insufficiency.…”
Section: Methodsmentioning
confidence: 99%
“…The preparation, antibiotic decontamination and cryopreservation of the homograft have been described elsewhere (Axelsson and Malm 2018).…”
Section: Donors and Homograftsmentioning
confidence: 99%
“…Short ischemic time intend to keep homograft quality and prevent adverse events after implantation, but studies indicate that it would be safe to implant homografts with prolonged ischemic time (Meyns et al 2005 ; Kalfa et al 2011 ; Axelsson and Malm 2018 ; Bester et al 2018 ). Looking at the homograft structure after prolonged ischemic time, it is shown that cellular viability decreases (Wallace et al 1992 ; Niwaya et al 1995 ; Gall et al 1998 ).…”
Section: Introductionmentioning
confidence: 99%